INS and Insulin resistance: The major metabolic defect of T2DM are; 1) insulin resistance where the sensitivity of insulin action in liver, muscle, and adipose tissue is impaired and 2) reduced ability of the pancreatic beta cells to produce enough insulin to compensate for insulin sensitivity loss.